Cargando…
Lipid Metabolite Biomarkers in Cardiovascular Disease: Discovery and Biomechanism Translation from Human Studies
Lipids represent a valuable target for metabolomic studies since altered lipid metabolism is known to drive the pathological changes in cardiovascular disease (CVD). Metabolomic technologies give us the ability to measure thousands of metabolites providing us with a metabolic fingerprint of individu...
Autores principales: | McGranaghan, Peter, Kirwan, Jennifer A., Garcia-Rivera, Mariel A., Pieske, Burkert, Edelmann, Frank, Blaschke, Florian, Appunni, Sandeep, Saxena, Anshul, Rubens, Muni, Veledar, Emir, Trippel, Tobias Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470800/ https://www.ncbi.nlm.nih.gov/pubmed/34564437 http://dx.doi.org/10.3390/metabo11090621 |
Ejemplares similares
-
Stroke Genomics: Current Knowledge, Clinical Applications and Future Possibilities
por: Appunni, Sandeep, et al.
Publicado: (2022) -
Performance of a cardiac lipid panel compared to four prognostic scores in chronic heart failure
por: McGranaghan, Peter, et al.
Publicado: (2021) -
Association between vitamin D deficiency and hypothyroidism: results from the National Health and Nutrition Examination Survey (NHANES) 2007–2012
por: Appunni, Sandeep, et al.
Publicado: (2021) -
Difference in 30-Day Readmission Rates After Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Roux-En-Y Gastric Bypass: a Propensity Score Matched Study Using ACS NSQIP Data (2015–2019)
por: Ahmed, Md Ashfaq, et al.
Publicado: (2023) -
Incremental prognostic value of a novel metabolite‐based biomarker score in congestive heart failure patients
por: McGranaghan, Peter, et al.
Publicado: (2020)